Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Fennec Pharmaceuticals Inc.US flagNASDAQ Capital Market
10.69
USD
-0.01
- -
305.52MMarket Cap

Fennec Pharmaceuticals Inc. (FENC) Stock Split History

Learn about Fennec Pharmaceuticals Inc.'s most recent 1-for-3 basis stock split on September 09, 2014. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Fennec Pharmaceuticals Inc.'s most recent stock split

Split Date: 2014-09-09
Split Ratio: 1:3
Price Before Split: $1.03
Price After Split: $0.34

Developer API

Get FENC split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/FENC

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 3.00 times fewer shares (a 1:3 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Fennec Pharmaceuticals Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2014-09-091:3Yes$1.03$0.34
2011-08-311:18YesN/AN/A
2005-08-021:5YesN/AN/A

About Fennec Pharmaceuticals Inc.

Company overview and industry information

Fennec Pharmaceuticals Inc. (FENC) operates in the Biotechnology industry. The recent 1-for-3 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Fennec Pharmaceuticals Inc. Summary

Last updated: 7/7/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.